statistiche ricercatore

Continente	#
NA - Nord America	560
AS - Asia	331
EU - Europa	276
SA - Sud America	43
AF - Africa	20
Continente sconosciuto - Info sul continente non disponibili	17
OC - Oceania	2
Totale	1.249

Nazione	#
US - Stati Uniti d'America	544
CN - Cina	136
SG - Singapore	89
IE - Irlanda	83
RU - Federazione Russa	45
HK - Hong Kong	37
IT - Italia	35
DE - Germania	32
BR - Brasile	29
VN - Vietnam	24
FR - Francia	19
ZA - Sudafrica	17
FI - Finlandia	14
GB - Regno Unito	12
CA - Canada	9
IN - India	8
PL - Polonia	8
BD - Bangladesh	7
TR - Turchia	7
JP - Giappone	6
AR - Argentina	5
LT - Lituania	4
MX - Messico	4
SE - Svezia	4
AT - Austria	3
BE - Belgio	3
ES - Italia	3
PK - Pakistan	3
AU - Australia	2
CO - Colombia	2
EC - Ecuador	2
JM - Giamaica	2
NL - Olanda	2
PH - Filippine	2
UA - Ucraina	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
AM - Armenia	1
BA - Bosnia-Erzegovina	1
BY - Bielorussia	1
CH - Svizzera	1
CL - Cile	1
CW - ???statistics.table.value.countryCode.CW???	1
CZ - Repubblica Ceca	1
GE - Georgia	1
GR - Grecia	1
GT - Guatemala	1
ID - Indonesia	1
IL - Israele	1
IQ - Iraq	1
IR - Iran	1
KZ - Kazakistan	1
ML - Mali	1
MN - Mongolia	1
MU - Mauritius	1
NP - Nepal	1
PE - Perù	1
PT - Portogallo	1
SA - Arabia Saudita	1
SC - Seychelles	1
SR - Suriname	1
UZ - Uzbekistan	1
Totale	1.233

Nome	#
Inter-observer agreement on the morphology of screening-detected lung cancer: beyond pulmonary nodules and masses	169
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome	143
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1	133
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome	128
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome	126
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3	120
Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome	96
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients	94
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)	92
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy	80
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment-Authors' reply	68
Totale	1.249

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	34	0	0	2	0	0	0	0	2	2	4	4	20
2022/2023	199	16	14	11	12	11	22	0	9	99	0	4	1
2023/2024	83	17	12	3	4	4	16	9	5	2	0	3	8
2024/2025	220	10	13	2	3	11	23	10	16	64	11	23	34
2025/2026	504	37	23	45	61	73	23	80	24	45	46	27	20
2026/2027	30	15	15	0	0	0	0	0	0	0	0	0	0
Totale													1.249